Followers | 283 |
Posts | 1162 |
Boards Moderated | 0 |
Alias Born | 10/04/2020 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, December 06, 2020 3:46:14 AM
That needed to be said!
When anyone invests in ENZC they're making a "triple company" 3-in-1 Investment:
Enzolytics
Immunotech
BioClonetics
ALL (3) are life saving Disruptive Biotechnology Companies engaged in the discovery, acquisition, and development of proprietary pharmaceutical therapeutics for treating serious life threatening infectious diseases that historically have no cure until now via their Patent protected non-toxicClone-3 Antibody and ITV-1 Vaccine for treating/eradicating:
AIDS/HIV
Covid-19
Rabies
Herpes
Influenza A
Influenza B
Influenza H1N1
Tetanus
Diphtheria
Anthrax
Smallpox
Ebola
If there ever was a winning combination of curative Biotechnologies this would have to be it!...a once in a lifetime investment opportunity worth $BILLIONS$ in the global marketplace!!!
Be well and prosper...
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM